JournalArta
Friday, November 20, 2026 · JakartaS&P 7,175.83 ▼2.02%USD/IDR 18,260 ▲0.02%
JournalArta
Global Edition
beyond headlines
Advertisement

Eli Lilly GLP-1 Pill Foundayo Wins Canadian Approval

Health Canada has authorized Eli Lilly’s daily weight-loss pill Foundayo, with pharmacy availability expected in January. The pill gives eligible adults another option alongside weekly injections, though dosing, costs and how quickly patients may see results can differ.

By Alistair Sterling
WIB2 min read
Eli Lilly GLP-1 Pill Foundayo Wins Canadian Approval
Eli Lilly GLP-1 Pill Foundayo Wins Canadian Approval

Health Canada authorized Eli Lilly’s daily GLP-1 pill Foundayo for weight loss and Type 2 diabetes on November 13. The decision gives eligible Canadians another option alongside weekly injections.

Eli Lilly spokesperson Ethan Pigott said the company expects the pills to reach pharmacies in January. Foundayo is already approved and available in the United States.

The Canadian authorization covers adults with obesity and people who are overweight with at least one related medical condition. Those conditions include high blood pressure and sleep apnea. Foundayo is also approved to help maintain weight loss.

Advertisement

Daily pills and weekly shots

Foundayo is taken once a day, while major injectable GLP-1 drugs such as Zepbound are administered weekly. The pill can be taken at any time, with or without food, according to Yale Medicine.

Dr. Hertzel Gerstein, a professor of medicine at McMaster University and Hamilton Health Sciences, said prescriptions often depend on what patients are most likely to follow.

“Some people would prefer the injection once a week and then forget about it. Some people will prefer the pill,” Gerstein said.

Foundayo contains orforglipron, a different active ingredient from the tirzepatide in Eli Lilly’s Zepbound injection. Foundayo starts at 0.8 milligrams and can rise to 17.2 milligrams. Zepbound starts at 2.5 milligrams and can reach 15 milligrams.

Advertisement

Another pill, Novo Nordisk’s Rybelsus, is already available in Canada. It is approved for managing Type 2 diabetes, not weight loss.

Novo Nordisk’s Wegovy pill is awaiting Health Canada approval. Its active ingredient, semaglutide, is also used in the Wegovy injection. Yale Medicine says the semaglutide-based pill must be taken on an empty stomach.

Results, costs and side effects

Participants taking 17.2 milligrams of Foundayo lost around 12% of their body weight on average over 72 weeks. The figure was 15% to 20% for people taking Eli Lilly’s injectable GLP-1 drugs.

Most Foundayo patients begin at the lowest dose and increase through six levels. Jennifer Lake, an assistant professor at the University of Toronto’s Leslie Dan Faculty of Pharmacy, said weight loss may take longer to appear with pills.

Advertisement

Lake said patients are expected to reach the third level, 6 milligrams, before seeing weight loss. That can mean about three months of treatment.

Insurance coverage also affects patients’ choices, Gerstein said. For uninsured patients in Canada, Zepbound can cost $275 to $650 per month, according to digital health platform Felix.

In the United States, Foundayo has a list price of US$650 for a 30-day supply without an insurance plan.

Common side effects of both oral and injectable GLP-1 drugs include nausea and vomiting. Eli Lilly warns against using Foundayo if a patient or family member has a history of thyroid cancer.

Lake advised patients not to stop their medication without consulting a health professional.

Advertisement
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1Joachim Klement to Sell Stocks After S&P 500 Signal
  2. 2Stock Market Today: Dow Slides 1.34% and VIX Jumps 15% at Midday
  3. 3Kenneth Walker’s Groin Injury Puts Cardinals Game in Doubt
  4. 4McDonald’s Workers’ Discrimination Claims Can Go Ahead
  5. 5Pat Cummins Faces Captaincy Doubts From Mitchell Johnson
Advertisement
Don't Miss

Latest News

All stories →
  1. Markets · StocksSpaceX Shares Fall From Peak as Nvidia Raises StakeNov 20
  2. Markets · StocksNvidia and Intel Shares Fall After Earnings and OutlookNov 20
  3. Markets · StocksNvidia Shares Hit 52-Week Low After Huang’s ExitNov 20
  4. Markets · StocksMicrosoft Shares Rise 0.40% After Nadella Apologizes for OutageNov 20
  5. Advertisement
  6. Markets · StocksPermian Resources Earnings Rise as Oil Prices and Output ClimbNov 20
  7. Markets · CryptoBitcoin Beats XRP in Five-Year $100-a-Month ComparisonNov 20
  8. Technology · GamingGTA 6 Lets Players Build a Romance Alongside CrimeNov 20
  9. Business · CompaniesAnalyst: Outages Fuel Emergency Supply Buying at CostcoNov 20